Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01964794 · ClinicalTrials.gov registry record
Improving Anticoagulant Therapy Through Warfarin Metabolite Profiling
A clinical trial, sponsored by University of Arkansas.
- Completed
- Registry status
- 60
- Enrollment target
NCT01964794 is a clinical trial that has completed, run by University of Arkansas. The registered enrollment target is 60 participants.
The verdict
NCT01964794 has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
Clinically relevant biomarkers for warfarin identified in this study will provide crucial leads for subsequent studies to assess their predictive value during anticoagulant therapy. This knowledge will aid stratifying risk among patients to improve therapeutic outcomes and decrease adverse drug events and associated health care costs. Collectively, these efforts will provide a critical foundation for future research using a metabolite biomarker strategy in a clinical setting to revolutionize warfarin therapy. Through its application, a real-time assessment of warfarin metabolism for each patient could lead to a truly personalized dosing strategy and improve patient safety for this life-saving drug.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-05 |
| Est. Completion | 2016-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01964794
The ClinicalTrials.gov registry entry for NCT01964794 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01964794 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01964794 about?
NCT01964794 is a clinical study titled "Improving Anticoagulant Therapy Through Warfarin Metabolite Profiling". Clinically relevant biomarkers for warfarin identified in this study will provide crucial leads for subsequent studies to assess their predictive value during anticoagulant therapy. This knowledge will aid stratifying risk among patients to improve therapeutic outcomes and decrease adverse drug even...
What is the current status of trial NCT01964794?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2012-05. Estimated completion is 2016-10.
Who is sponsoring clinical trial NCT01964794?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.